Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 24, 2004
Protein biomarkers and drug design for cancer treatmentsJ H Hanke, K R Webster, L V Ronco
Lymphokine and Cytokine Research|October 1, 1992
FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNAJ H Hanke, L N Nichols, M E Coon
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 1, 1995
Role of tyrosine kinases in lymphocyte activation: targets for drug interventionJ H Hanke, B A Pollok, P S Changelian
Advances in Experimental Medicine and Biology|January 1, 1987
Trinitrophenyl reactive T-cell clones in functional and molecular analysis of the HLA-D regionR R Rich, J H Hanke, R G Cook
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1997
Appropriate developmental expression of human CD8 beta in transgenic miceL J Kieffer, L Yan, J H Hanke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinantsJ H Hanke, R G Cook, L A Lopez, et al.
Human Immunology|September 1, 1985
Class II determinants recognized by TNP-specific cloned human T cell linesJ H Hanke, M F Brown, M S Pollack, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Identification of murine nuclear proteins that bind to the conserved octamer sequence of the immunoglobulin promoter regionJ H Hanke, N F Landolfi, P W Tucker, et al.
Pageof 3